How high a bar to change neoadjuvant therapy for triple-negative breast cancer?
Hematology-Oncology Fellowship Program, Rhode Island Hospital, 593 Eddy St, Providence, RI 02903, USA.
Benjamin
B
Kuritzky
Program in Women's Oncology, Women & Infants Hospital of Rhode Island & Warren Alpert Medical School of Brown University, 101 Dudley Street, Providence, RI 02905, USA.
William M
WM
Sikov
D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D064726:Triple Negative Breast Neoplasms / Q000628:therapy*
bevacizumab; carboplatin; neoadjuvant chemotherapy; triple-negative breast cancer